Molecular Modeling Market Outlook 2026-2030: Investment Trends, Strategic Profiles and Revenue Share Outlook
Dublin, Sept. 14, 2026 (GLOBE NEWSWIRE) -- "Molecular Modeling Market Report 2026" has been added to ResearchAndMarkets.com's offering.
Molecular Modeling Market to Reach $20.08 Billion by 2030 as AI and Personalized Medicine Accelerate Growth
The global molecular modeling market is experiencing rapid expansion as pharmaceutical companies, biotechnology firms, research centers, and academic institutions increase their use of computational tools for drug discovery and development. The market is projected to grow from $9.44 billion in 2025 to $10.89 billion in 2026, representing a compound annual growth rate (CAGR) of 15.4%.
Historic molecular modeling market growth has been supported by rising reliance on computational drug design, increasing academic research activity, greater adoption of molecular mechanics tools, and strong demand for three-dimensional structural visualization. Continued improvements in computing performance and modeling capabilities have also enabled researchers to analyze increasingly complex chemical and biological systems.
The molecular modeling market is forecast to reach $20.08 billion by 2030, expanding at a CAGR of 16.5%. Key growth drivers include increased pharmaceutical investment in simulation technologies, wider integration of cloud computing, demand for faster and more cost-efficient drug discovery, and continued development of quantum chemistry capabilities. Artificial intelligence is also expected to strengthen predictive accuracy and improve the efficiency of molecular analysis.
Major molecular modeling market trends include the integration of AI-powered molecular simulation tools, adoption of cloud-based modeling platforms, and increased automation across computational chemistry workflows. The industry is also seeing greater use of augmented reality and virtual reality interfaces for structural visualization, alongside the development of precision-based predictive modeling techniques. These advances are helping research teams evaluate molecular interactions, prioritize potential compounds, and streamline development processes.
The growing adoption of personalized medicine is expected to be a significant driver of market expansion. Molecular modeling supports personalized treatment development by helping researchers predict patient responses to therapies, design targeted drug candidates, and optimize treatment strategies based on genetic and molecular profiles. In February 2024, the Personalized Medicine Coalition reported that the US Food and Drug Administration approved 16 new personalized treatments for patients with rare diseases in 2023, compared with six in 2022. This increase highlights the expanding role of precision medicine and the supporting technologies used to develop tailored therapies.
Innovation in drug design platforms is further shaping the molecular modeling market. In August 2023, UK-based drug discovery solutions provider Cresset Group launched Flare V7, an advanced platform combining ligand-based and structure-based approaches for small-molecule discovery. The platform includes ensemble docking capabilities, expanded Quantum Mechanics and Quantitative Structure-Activity Relationship methodologies, and tools for troubleshooting Free Energy Perturbation experiments. It also supports dynamics trajectory analysis and ligand structure preparation, strengthening computational workflows across drug discovery programs.
Strategic acquisitions are also expanding the use of artificial intelligence and machine learning within molecular modeling. In May 2023, US-based clinical-stage biotechnology company Recursion Pharmaceuticals acquired Canada-based Valence Discovery Inc. for an undisclosed amount. The transaction integrated Valence's AI-driven chemistry engine into Recursion's operations, enhancing its molecular modeling capabilities and accelerating digital chemistry workflows for drug discovery. Valence Discovery specializes in predictive chemistry solutions supported by artificial intelligence and machine learning.
North America was the largest region in the molecular modeling market in 2025, supported by established pharmaceutical and biotechnology industries, advanced research infrastructure, and strong investment in computational drug discovery. Asia-Pacific is expected to be the fastest-growing region during the forecast period. The regions covered by the molecular modeling market include Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. Countries covered include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, the United Kingdom, the United States, Canada, Italy, and Spain.
Markets Covered:
1) By Product: Software; Services
2) By Approach: Molecular Mechanics Approach; Quantum Chemistry Approach
3) By Application: Drug Development; Drug Discovery; Other Applications
4) By End-User: Pharmaceutical And Biotechnology Companies; Research Centers And Academic Institutions; Other End Users
Subsegments:
1) By Software: Molecular Visualization Software; Molecular Dynamics Software; Quantum Chemistry Software; Docking Software; Simulation Software; Other Specialized Software
2) By Services: Consulting Services; Custom Modeling Services; Training And Support Services; Data Analysis Services; Cloud-Based Services
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Key Attributes:
Companies Featured
The companies featured in this Molecular Modeling market report include:
For more information about this report visit https://www.researchandmarkets.com/r/aw6s2t
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.